These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6927819)

  • 1. Nomifensine test does not differentiate hyperprolactinemia associated with and without radiologic abnormalities in the sella turcica.
    Canales ES; Cano C; Ablanedo J; Zárate A
    Horm Res; 1981; 15(4):213-7. PubMed ID: 6927819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of nomifensine administration to discriminate between tumorous and nontumorous hyperprolactinemia.
    Ferrari C; Crosignani PG; Caldara R; Picciotti MC; Malinverni A; Barattini B; Rampini P; Telloli P
    J Clin Endocrinol Metab; 1980 Jan; 50(1):23-6. PubMed ID: 7188615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tests of prolactin secretion in the diagnosis of hyperprolactinemic states: nomifensine and domperidone.
    Massara F; Genazzani AR; Camanni F; De Leo V; Molinatti GM; Müller EE
    Fertil Steril; 1981 Feb; 35(2):149-54. PubMed ID: 7202740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic difficulties in the organic form of hyperprolactinemia].
    Bŭrdarova I; Trepechov S; Markovski N; Tomov A; Zhekova V
    Akush Ginekol (Sofiia); 1984; 23(5):412-5. PubMed ID: 6517214
    [No Abstract]   [Full Text] [Related]  

  • 5. Nomifensine: diagnostic test in hyperprolactinemic states.
    Müller EE; Genazzani AR; Murru S
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1352-7. PubMed ID: 263356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional evaluation of the adenohypophysis with metoclopramide in hyperprolactinemic-amenorrheic women in relation to radiological findings on the sella turcica.
    Seki K; Uesato T; Kato K; Shima K
    Endocrinol Jpn; 1984 Dec; 31(6):733-9. PubMed ID: 6532792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors.
    Kamoi K; Tchuchida I; Sato H; Tanaka R; Ishiguro T; Kaneko K; Iwasaki Y; Shibata A
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1285-7. PubMed ID: 7298805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomifensine in the diagnosis of hyperprolactinemia.
    Gullo D; Carmina E; Mogavero G; Perino A; Venezia R
    Acta Eur Fertil; 1981 Dec; 12(4):299-306. PubMed ID: 7342611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrimination of prolactinoma from hyperprolactinemic non-functioning adenoma.
    Hong JW; Lee MK; Kim SH; Lee EJ
    Endocrine; 2010 Feb; 37(1):140-7. PubMed ID: 20963563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin-secreting pituitary microadenoma: detection and evaluation.
    Wiebe RH; Hammond CB; Handwerger S
    Fertil Steril; 1978 Mar; 29(3):282-6. PubMed ID: 640047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prolactinoma: radiologic appearance of the sella turcica].
    Vezina JL
    Neurochirurgie; 1981; 27 Suppl 1():19-28. PubMed ID: 7279097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin and thyroid-stimulating hormone responses to thyrotropin-releasing hormone in cases of hyperprolactinemia with normal and abnormal sella tomograms.
    Badawy SZ; Moses A; Streeten D; Marshall L; Marlin D; Notman D
    Int J Fertil; 1983; 28(4):213-8. PubMed ID: 6142012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approach to the patient with persistent hyperprolactinemia and negative sellar imaging.
    Glezer A; Bronstein MD
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2211-6. PubMed ID: 22774208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Indirect dopamine agonists and direct dopamine antagonists in the diagnosis of hyperprolactinemia].
    De Leo V; Massafra C; La Marca S; De Leo M; Venturi C; Urbani TM; Genazzani AR
    Boll Soc Ital Biol Sper; 1982 Aug; 58(16):1025-31. PubMed ID: 7138672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modern management of prolactinoma.
    Reyniak JV
    J Reprod Med; 1983 Apr; 28(4):257-63. PubMed ID: 6864668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin response to perphenazine. A sensitive and specific test for pituitary tumor in hyperprolactinemic women.
    Mattox JH; Fortunato SJ
    J Reprod Med; 1986 Dec; 31(12):1098-101. PubMed ID: 3795197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term radiographic follow-up of the sella turcica in hyperprolactinaemic women.
    Rasmussen C; Larsson SG; Bergh T
    Aust N Z J Obstet Gynaecol; 1990 Aug; 30(3):257-64. PubMed ID: 2256866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the pituitary. Patients with suspected prolactin-producing tumors.
    Swanson JA; Jacoby CG; Sherman BM; Dolan KD; Chapler FK
    Obstet Gynecol; 1978 Jul; 52(1):67-72. PubMed ID: 567309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathologic hyperprolactinemia. I. Positive diagnosis and etiology].
    Vermeulen C; Bouallouche A; Brerault JL; Cathelineau G
    Sem Hop; 1982 Sep; 58(34):1957-71. PubMed ID: 6293080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacodynamic metoclopramide (cerucal) test in differential diagnosis of hypoprolactinemic hypogonadism syndrome in women].
    Balabolkin MI; Gerasimov GA; Liubimov AV
    Akush Ginekol (Mosk); 1990 Feb; (2):54-7. PubMed ID: 2339765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.